Clinical trial
Phase Angle as a New Possible Prognostic Factor in Chronic Intestinal Inflammatory Diseases
NCT05106738 is registered in ClinicalTrials.gov with University of Bari as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase Angle as a New Possible Prognostic Factor in Chronic Intestinal Inflammatory Diseases
- Lead sponsor
- University of Bari
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 1, 2021
- Completion date
- November 30, 2023
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
c-reactive protein, inflammatory bowel diseases, leukocyte l1 antigen complex, mucosal inflammation